Megan L Casey1, Jacek M Mazurek1. 1. Surveillance Branch, Respiratory Health Division, National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), Morgantown, West Virginia.
Abstract
INTRODUCTION: Existing epidemiologic information on silicosis relies on mortality data. METHODS: We analyzed health insurance claims and enrollment information from 49 923 987 fee-for-service (FFS) Medicare beneficiaries aged ≥65 from 1999 to 2014. Three different definitions were developed to identify silicosis cases and results are presented as ranges of values for the three definitions. RESULTS: Among FFS beneficiaries, 10 026-19 696 fit the silicosis case definitions (16-year prevalence: 20.1-39.5 per 100 000) with the highest prevalence among North American Natives (87.2-213.6 per 100 000) and those in New Mexico (83.9-203.4 per 100 000). The annual average prevalence had a significant (P < 0.05) 2-5% annual decline from 2005 to 2014. The average annual number of incident cases had a significant 3-16% annual decline from 2007 to 2014. CONCLUSIONS: Silicosis is a prevalent disease among Medicare beneficiaries aged ≥65, with variation across the country. Morbidity data from health insurance claims can provide a more complete picture of silicosis burden. Published 2019. This article is a U.S. Government work and is in the public domain in the USA.
INTRODUCTION: Existing epidemiologic information on silicosis relies on mortality data. METHODS: We analyzed health insurance claims and enrollment information from 49 923 987 fee-for-service (FFS) Medicare beneficiaries aged ≥65 from 1999 to 2014. Three different definitions were developed to identify silicosis cases and results are presented as ranges of values for the three definitions. RESULTS: Among FFS beneficiaries, 10 026-19 696 fit the silicosis case definitions (16-year prevalence: 20.1-39.5 per 100 000) with the highest prevalence among North American Natives (87.2-213.6 per 100 000) and those in New Mexico (83.9-203.4 per 100 000). The annual average prevalence had a significant (P < 0.05) 2-5% annual decline from 2005 to 2014. The average annual number of incident cases had a significant 3-16% annual decline from 2007 to 2014. CONCLUSIONS:Silicosis is a prevalent disease among Medicare beneficiaries aged ≥65, with variation across the country. Morbidity data from health insurance claims can provide a more complete picture of silicosis burden. Published 2019. This article is a U.S. Government work and is in the public domain in the USA.
Authors: Patricia L Schleiff; Jacek M Mazurek; Mary Jo Reilly; Kenneth D Rosenman; Martha B Yoder; Margaret E Lumia; Karen Worthington Journal: MMWR Morb Mortal Wkly Rep Date: 2016-10-14 Impact factor: 17.586
Authors: Gary K Friedman; Robert Harrison; Heidi Bojes; Karen Worthington; Margaret Filios Journal: MMWR Morb Mortal Wkly Rep Date: 2015-02-13 Impact factor: 17.586
Authors: Katherine E Mues; Alexander Liede; Jiannong Liu; James B Wetmore; Rebecca Zaha; Brian D Bradbury; Allan J Collins; David T Gilbertson Journal: Clin Epidemiol Date: 2017-05-09 Impact factor: 4.790
Authors: Ryan F Hoy; Mohamed F Jeebhay; Catherine Cavalin; Weihong Chen; Robert A Cohen; Elizabeth Fireman; Leonard H T Go; Antonio León-Jiménez; Alfredo Menéndez-Navarro; Marcos Ribeiro; Paul-André Rosental Journal: Respirology Date: 2022-03-18 Impact factor: 6.175
Authors: Jan Michael Jesse Lomanta; Mary Antonette Atienza; Juan Raphael M Gonzales; Eric Jason Bautista Amante; Sheen C Urquiza; Hanna Lucero-Orillaza; Joel Marquez Santiaguel Journal: Am J Case Rep Date: 2022-08-10
Authors: José Jesús Blanco-Pérez; Sara Blanco-Dorado; Javier Rodríguez-García; Mª Elena Gonzalez-Bello; Ángel Salgado-Barreira; Adriana Carolina Caldera-Díaz; Abel Pallarés-Sanmartín; Alberto Fernandez-Villar; Francisco Javier González-Barcala Journal: Sci Rep Date: 2021-06-25 Impact factor: 4.379